Cargando…

Combinatorial Therapeutic Effect of Inhibitors of Aldehyde Dehydrogenase and Mitochondrial Complex I, and the Chemotherapeutic Drug, Temozolomide against Glioblastoma Tumorspheres

Resident cancer cells with stem cell-like features induce drug tolerance, facilitating survival of glioblastoma (GBM). We previously showed that strategies targeting tumor bioenergetics present a novel emerging avenue for treatment of GBM. The objective of this study was to enhance the therapeutic e...

Descripción completa

Detalles Bibliográficos
Autores principales:	Park, Hun Ho, Park, Junseong, Cho, Hye Joung, Shim, Jin-Kyoung, Moon, Ju Hyung, Kim, Eui Hyun, Chang, Jong Hee, Kim, Soo Youl, Kang, Seok-Gu
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2021
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827959/ https://www.ncbi.nlm.nih.gov/pubmed/33429981 http://dx.doi.org/10.3390/molecules26020282

Ejemplares similares

Combined effects of niclosamide and temozolomide against human glioblastoma tumorspheres
por: Oh, Hyeong-Cheol, et al.
Publicado: (2020)

Etomoxir, a carnitine palmitoyltransferase 1 inhibitor, combined with temozolomide reduces stemness and invasiveness in patient-derived glioblastoma tumorspheres
por: Shim, Jin-Kyoung, et al.
Publicado: (2022)

Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program
por: Park, Junseong, et al.
Publicado: (2023)

Inhibiting stemness and invasive properties of glioblastoma tumorsphere by combined treatment with temozolomide and a newly designed biguanide (HL156A)
por: Choi, Junjeong, et al.
Publicado: (2016)

A lignan from Alnus japonica inhibits glioblastoma tumorspheres by suppression of FOXM1
por: Shim, Jin-Kyoung, et al.
Publicado: (2022)

Co-expression of cancer driver genes: IDH-wildtype glioblastoma-derived tumorspheres
por: Yoon, Seon-Jin, et al.
Publicado: (2020)

Success of tumorsphere isolation from WHO grade IV gliomas does not correlate with the weight of fresh tumor specimens: an immunohistochemical characterization of tumorsphere differentiation
por: Sung, Kyoung Su, et al.
Publicado: (2016)

Gossypol Suppresses Growth of Temozolomide-Resistant Glioblastoma Tumor Spheres
por: Kim, Hee Yeon, et al.
Publicado: (2019)

Association between survival and levetiracetam use in glioblastoma patients treated with temozolomide chemoradiotherapy
por: Roh, Tae Hoon, et al.
Publicado: (2020)

Combinatorial Effect of PLK1 Inhibition with Temozolomide and Radiation in Glioblastoma
por: Pandey, Arvind, et al.
Publicado: (2021)

Disulfiram, a Re-positioned Aldehyde Dehydrogenase Inhibitor, Enhances Radiosensitivity of Human Glioblastoma Cells In Vitro
por: Koh, Hyeon Kang, et al.
Publicado: (2019)

Aldehyde dehydrogenase is used by cancer cells for energy metabolism
por: Kang, Joon Hee, et al.
Publicado: (2016)

Profiling Anti-Apoptotic BCL-xL Protein Expression in Glioblastoma Tumorspheres
por: Fanfone, Deborah, et al.
Publicado: (2020)

Effect of the JAK2/STAT3 inhibitor SAR317461 on human glioblastoma tumorspheres
por: Mukthavaram, Rajesh, et al.
Publicado: (2015)

Long-term outcomes of concomitant chemoradiotherapy with temozolomide for newly diagnosed glioblastoma patients: A single-center analysis
por: Roh, Tae Hoon, et al.
Publicado: (2017)

Mesenchymal Stem-Like Cells Derived from the Ventricle More Effectively Enhance Invasiveness of Glioblastoma Than Those Derived from the Tumor
por: Park, Junseong, et al.
Publicado: (2023)

Lipid Peroxidation Plays an Important Role in Chemotherapeutic Effects of Temozolomide and the Development of Therapy Resistance in Human Glioblastoma
por: Wu, Wei, et al.
Publicado: (2020)

Inhibition of O-GlcNAcylation Reduces Cell Viability and Autophagy and Increases Sensitivity to Chemotherapeutic Temozolomide in Glioblastoma
por: Leonel, Amanda V., et al.
Publicado: (2023)

Alcohol dehydrogenase and aldehyde dehydrogenase in malignant neoplasms
por: Orywal, Karolina, et al.
Publicado: (2016)

Repurposing Penfluridol in Combination with Temozolomide for the Treatment of Glioblastoma
por: Kim, Hyungsin, et al.
Publicado: (2019)

The aqueous extract of brucea javanica reduces tumorigenicity of human lung cancer tumorspheres
por: Kim, Seung-Hun, et al.
Publicado: (2021)

Gastric cancer depends on aldehyde dehydrogenase 3A1 for fatty acid oxidation
por: Lee, Jae-Seon, et al.
Publicado: (2019)

Transcriptome profiling-based identification of prognostic subtypes and multi-omics signatures of glioblastoma
por: Park, Junseong, et al.
Publicado: (2019)

Inhibition of Wnt/beta-catenin signaling downregulates expression of aldehyde dehydrogenase isoform 3A1 (ALDH3A1) to reduce resistance against temozolomide in glioblastoma in vitro
por: Suwala, Abigail Kora, et al.
Publicado: (2018)

Understanding the influence of substrate when growing tumorspheres
por: Benítez, Lucía, et al.
Publicado: (2021)

Tumor Microenvironment and Genes Affecting the Prognosis of Temozolomide-Treated Glioblastoma
por: Jang, Yena, et al.
Publicado: (2023)

Functional polymorphism in aldehyde dehydrogenase-2 gene associated with risk of tuberculosis
por: Park, Seung Kyu, et al.
Publicado: (2014)

Concurrent Chemoradiotherapy with Temozolomide Followed by Adjuvant Temozolomide for Newly Diagnosed Glioblastoma Patients: A Retrospective Multicenter Observation Study in Korea
por: Kim, Byung Sup, et al.
Publicado: (2017)

Insights into Aldehyde Dehydrogenase Enzymes: A Structural Perspective
por: Shortall, Kim, et al.
Publicado: (2021)

Mitochondrial aldehyde dehydrogenase and cardiac diseases
por: Chen, Che-Hong, et al.
Publicado: (2010)

SAXS fingerprints of aldehyde dehydrogenase oligomers
por: Tanner, John J.
Publicado: (2015)

Aldehyde Dehydrogenase, Liver Disease and Cancer
por: Wang, Wenjun, et al.
Publicado: (2020)

Aldehyde Dehydrogenase 1 in Gastric Cancer
por: Wang, Ling, et al.
Publicado: (2022)

Assessing Spatial Distribution of Multicellular Self-Assembly Enables the Prediction of Phenotypic Heterogeneity in Glioblastoma
por: Cha, Junghwa, et al.
Publicado: (2022)

Aldehyde dehydrogenase inhibition combined with phenformin treatment reversed NSCLC through ATP depletion
por: Kang, Joon Hee, et al.
Publicado: (2016)

Reduced aldehyde dehydrogenase expression in preeclamptic decidual mesenchymal stem/stromal cells is restored by aldehyde dehydrogenase agonists
por: Kusuma, Gina D., et al.
Publicado: (2017)

Prediction of Response to Concurrent Chemoradiotherapy with Temozolomide in Glioblastoma: Application of Immediate Post-Operative Dynamic Susceptibility Contrast and Diffusion-Weighted MR Imaging
por: Lee, Eun Kyoung, et al.
Publicado: (2015)

Structural insights into the production of 3-hydroxypropionic acid by aldehyde dehydrogenase from Azospirillum brasilense
por: Son, Hyeoncheol Francis, et al.
Publicado: (2017)

Engineering an aldehyde dehydrogenase toward its substrates, 3-hydroxypropanal and NAD(+), for enhancing the production of 3-hydroxypropionic acid
por: Park, Ye Seop, et al.
Publicado: (2017)

Temozolomide resistance in glioblastoma multiforme
por: Lee, Sang Y.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_gjtdvbgdq1jupsh7jcm6fp59gp